To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 5 (PDF)

Found: Visual impairment and blindness (excl colour blindness) Blindness 1 0 Blindness transient

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 4 (PDF)

Found: Eye discharge 7 0 Eye inflammation 1 0 Eye irritation 3 0 Eye pruritus 16 0

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 7 November 2022
Document: Freedom of Information request (FOI 22/1040) - attachment 1 (PDF)

Found: Eye discharge 7 0 Eye inflammation 1 0 Eye irritation 3 0 Eye pruritus 16 0

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 29 August 2022
Document: FOI 22/875 - attachment 6 (PDF)

Found: and associated manifestations Eye allergy 1 0 Eye inflammation 1 0 Eye irritation

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 12 (PDF)

Found: disorders Conjunctival haemorrhage 1 0 Ocular bleeding and vascular disorders NEC Eye

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/996) - attachment 3 (PDF)

Found: disorders Conjunctival haemorrhage 1 0 Ocular bleeding and vascular disorders NEC Eye

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 7 November 2022
Document: Freedom of Information request (FOI 22/1069) - attachment 2 (PDF)

Found: disorders Conjunctival haemorrhage 1 0 Ocular bleeding and vascular disorders NEC Eye

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 5 December 2022
Document: FOI 22/1102 - attachment 1 (PDF)

Found: disorders Conjunctival haemorrhage 1 0 Ocular bleeding and vascular disorders NEC Eye

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 14 November 2022
Document: Freedom of Information request (FOI 22/951) - attachment 3 (PDF)

Found: disorders Conjunctival haemorrhage 1 0 Ocular bleeding and vascular disorders NEC Eye

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022
Document: Freedom of Information request (FOI 22/1107) - attachment 3 (PDF)

Found: disorders Conjunctival haemorrhage 1 0 Ocular bleeding and vascular disorders NEC Eye